AVTR
Avantor, Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$15.67
+0.48%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$15.88
From 52W high−9.40%
Volume4.09M
Market cap$10.61B
P/E (TTM)31.3x
P/S (TTM)1.6x
Div yield—
Key dataNov 4, 2026
Open
$15.88
From 52W high
−9.40%
Volume
4.09M
Market cap
$10.61B
ValuationView details →
P/E (Fwd)
17.9x
EV/EBITDA
15.2x
P/E (TTM)
31.3x
RSI (14)
42.5
MomentumView details →
1D Return
+0.48%
YTD Return
+35.73%
SummaryUpdated Sep 1, 2026
Avantor, Inc. (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the life sciences and advanced technology industries. Founded in 1904 and headquartered in Radnor, Pennsylvania, the company went public in May 2019. Avantor serves customers across biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide. The company has evolved from its origins as a specialty chemicals provider into a comprehensive solutions partner for organizations conducting critical research, development, and production activities.
Similar companies
Latest newsMore news →
Avantor reported quarterly earnings of $0.22 per share, above the Zacks Investment Research, Inc. consensus estimate of $0.21 per share.7d agoAvantor reported third-quarter 2026 revenue of $1.6983 billion and net income of $203.4 million, and provided fiscal 2026 revenue guidance of $1.698 billion to $1.703 billion and diluted EPS guidance of $0.81 to $0.83.7d agoAvantor reported third-quarter 2026 net sales of $1,698.3 million, up 4.6% (5.2% organically), diluted GAAP EPS of $0.30 and adjusted EPS of $0.22.7d ago